Graeme C.M. Smith

Also affiliated with Agios Pharmaceuticals (United States), Acacia Pharma (United Kingdom)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy”.

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Nature(2005)10.1038/nature03445

N/A

1.3DataRank · unranked

6630 citations

Nuala McCabe, Christopher J. Lord, Damian A. Johnson, Tobias B. Richardson, Manuela Santarosa +11 more

Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gaps

Molecular Cell(2021)10.1016/j.molcel.2021.09.005

N/A

0DataRank · unranked

94 citations

Vivek Tripathi, Ingrid van der Heijden, Ke Cong, Eleni-Maria Manolika, Jinhyuk Bhin +16 more

Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-1763

N/A

0DataRank · unranked

13 citations

Virginia Giuliani, Wei‐Lien Wang, Daniel J. McGrail, Christopher A. Bristow, Natalie Y.L. Ngoi +46 more